Anne‐Lise Børresen‐Dale

2.2k citations

20 papers · 1.2k indexed · h-index 15

Co-authors: Thérese Sørlie Per Eystein Lønning Robert Tibshirani Vessela N. Kristensen Pei Wang Anna Bergamaschi Tina Hernandez‐Boussard Jonathan R. Pollack
Topics: Epigenetics and DNA Methylation (9 papers)Cancer Genomics and Diagnostics (6 papers)Cancer-related molecular mechanisms research (3 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Proceedings of the National Academy of Sciences Bioinformatics Cancer Research
Partner nations: Norway Sweden France

In The Last Decade

Anne‐Lise Børresen‐Dale

20 papers receiving 1.2k citations

Peers

Countries citing papers authored by Anne‐Lise Børresen‐Dale

Since Specialization

Citations

This map shows the geographic impact of Anne‐Lise Børresen‐Dale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Lise Børresen‐Dale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Lise Børresen‐Dale more than expected).

Fields of papers citing papers by Anne‐Lise Børresen‐Dale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Lise Børresen‐Dale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Lise Børresen‐Dale. The network helps show where Anne‐Lise Børresen‐Dale may publish in the future.

Co-authorship network of co-authors of Anne‐Lise Børresen‐Dale

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Lise Børresen‐Dale. A scholar is included among the top collaborators of Anne‐Lise Børresen‐Dale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Lise Børresen‐Dale. Anne‐Lise Børresen‐Dale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer 2024 ·Molecular Oncology ·Thomas Fleischer,Mads H. Haugen,(unknown),Laxmi Silwal‐Pandit,Anne‐Lise Børresen‐Dale,Ingrid Hedenfalk,Thomas Hatschek,Jörg Tost,Olav Engebraaten,Vessela N. Kristensen	3
2	Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer 2021 ·Genome Medicine ·(unknown),Miriam R. R. Aure,Thomas Fleischer,(unknown),(unknown),Jaime A. Castro-Mondragón,Anne‐Lise Børresen‐Dale,Jörg Tost,(unknown),Anthony Mathelier,Xavier Tekpli,Vessela N. Kristensen	38
3	N‐glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome 2018 ·Molecular Oncology ·Thilde Terkelsen,Vilde Drageset Haakensen,Radka Saldova,Pavel Gromov,Merete Kjær Hansen,Henning Stöckmann,Ole Christian Lingjærde,Anne‐Lise Børresen‐Dale,Elena Papaleo,Åslaug Helland,Pauline M. Rudd,Irina Gromova	22
4	Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics 2018 ·OncoImmunology ·(unknown),Jaime A. Espinoza,(unknown),Manuela Zucknick,Surendra Kumar,Vilde Drageset Haakensen,Torben Lüders,Olav Engebraaten,Anne‐Lise Børresen‐Dale,Jon Amund Kyte,Pavel Gromov,Bjørn Naume,Vessela N. Kristensen,Irina Gromova,Xavier Tekpli	28
5	Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity 2017 ·Oncotarget ·Ruth Dannenfelser,(unknown),Andliena Tahiri,Josie Ursini‐Siegel,Hans Kristian Moen Vollan,Vilde Drageset Haakensen,Åslaug Helland,Bjørn Naume,Carlos Caldas,Anne‐Lise Børresen‐Dale,Vessela N. Kristensen,Olga G. Troyanskaya	30
6	The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma 2016 ·Cancer Research ·Vandana Sandhu,David C. Wedge,Inger Marie Bowitz Lothe,Knut Jørgen Labori,Stefan C. Dentro,Trond Buanes,Martina L. Skrede,(unknown),Else Munthe,Ola Myklebost,Ole Christian Lingjærde,Anne‐Lise Børresen‐Dale,Tone Ikdahl,Peter Van Loo,Silje Nord,Elin H. Kure	27
7	Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes 2016 ·Cancer & Metabolism ·Tonje H. Haukaas,Leslie R. Euceda,Guro F. Giskeødegård,Santosh Lamichhane,Marit Krohn,Sandra Jernström,Miriam R. R. Aure,Ole Christian Lingjærde,Ellen Schlichting,Øystein Garred,Eldri U. Due,Gordon B. Mills,Kristine Kleivi Sahlberg,Anne‐Lise Børresen‐Dale,Tone F. Bathen	56
8	Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes 2015 ·International Journal of Cancer ·Balázs Győrffy,Giulia Bottai,Thomas Fleischer,Gyöngyi Munkácsy,Jan Budczies,Laura Paladini,Anne‐Lise Børresen‐Dale,Vessela N. Kristensen,Libero Santarpia	128
9	Genome-wide DNA methylation profiles in progression to 2014 ·Genome Biology ·Thomas Fleischer,Arnoldo Frigessi,Kevin C. Johnson,Hege Edvardsen,Nizar Touleimat,Jovana Klajic,Margit Riis,Vilde Drageset Haakensen,Fredrik Wärnberg,Bjørn Naume,Åslaug Helland,Anne‐Lise Børresen‐Dale,Jörg Tost,Brock C. Christensen,Vessela N. Kristensen	25
10	Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors 2013 ·BMC Cancer ·Jovana Klajic,Thomas Fleischer,Emelyne Dejeux,Hege Edvardsen,Fredrik Wärnberg,I. K. Bukholm,Per Eystein Lønning,Hiroko Kato Solvang,Anne‐Lise Børresen‐Dale,Jörg Tost,Vessela N. Kristensen	59
11	Abstract 1956: High-throughput screens identify microRNAs essential for HER2-positive breast cancer cell growth. 2013 ·Cancer Research ·Suvi‐Katri Leivonen,Kristine Kleivi Sahlberg,Rami Mäkelä,Olli Kallioniemi,Anne‐Lise Børresen‐Dale,Merja Perälä	1
12	Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling 2011 ·Proceedings of the National Academy of Sciences ·Vessela N. Kristensen,Charles Vaske,Josie Ursini‐Siegel,Peter Van Loo,Silje Nord,Ravi Sachidanandam,Thérese Sørlie,Fredrik Wärnberg,Vilde Drageset Haakensen,Åslaug Helland,Bjørn Naume,Charles M. Perou,David Haussler,Olga G. Troyanskaya,Anne‐Lise Børresen‐Dale	110
13	Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer 2010 ·Breast Cancer Research ·(unknown),Jo Anders Rønneberg,Fredrik Wärnberg,Johan Botling,Florence Busato,J Jovanović,Hiroko Kato Solvang,Ida Bukholm,Anne‐Lise Børresen‐Dale,Vessela N. Kristensen,Thérese Sørlie,Jörg Tost	122
14	DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response 2010 ·Molecular Cancer ·Emelyne Dejeux,Jo Anders Rønneberg,Hiroko Kato Solvang,I. K. Bukholm,Stephanie Geisler,Turid Aas,Marta Gut,Anne‐Lise Børresen‐Dale,Per Eystein Lønning,Vessela N. Kristensen,Jörg Tost	103
15	Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer 2007 ·International Journal of Cancer ·Montserrat García‐Closas,Vessela N. Kristensen,Anita Langerød,Ying Qi,Meredith Yeager,Laurie Burdett,Robert Welch,Jolanta Lissowska,Beata Pepłońska,Louise A. Brinton,Daniela S. Gerhard,Inger Torhild Gram,Charles M. Perou,Anne‐Lise Børresen‐Dale,Stephen J. Chanock	46
16	Disease-specific genomic analysis: identifying the signature of pathologic biology 2007 ·Bioinformatics ·Monica Nicolau,Robert Tibshirani,Anne‐Lise Børresen‐Dale,Stefanie S. Jeffrey	41
17	Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer 2006 ·Genes Chromosomes and Cancer ·Anna Bergamaschi,Young Ho Kim,Pei Wang,Thérese Sørlie,Tina Hernandez‐Boussard,Per Eystein Lønning,Robert Tibshirani,Anne‐Lise Børresen‐Dale,Jonathan R. Pollack	368
18	Protein Expression and Prognostic Value of Genes in the erb-b Signaling Pathway in Advanced Ovarian Carcinomas 2005 ·American Journal of Clinical Pathology ·Yun Wang,Gunnar B. Kristensen,Åslaug Helland,Jahn M. Nesland,Anne‐Lise Børresen‐Dale,Ruth Holm	14
19	*BRCA1* mutation screening using restriction endonuclase fingerprinting‐single‐strand conformation polymorphism in an automated capillary electrophoresis system 2002 ·Electrophoresis ·(unknown),(unknown),Jan Pedersen,(unknown),Kjell M. Tveit,(unknown),Anne‐Lise Børresen‐Dale,Tone Ikdahl Andersen	8
20	Nobelprisen i kjemi 1993--polymerase-kjedereaksjonen og dirigert mutagenese. 1993 ·Tidsskrift for Den Norske Laegeforening ·Anne‐Lise Børresen‐Dale	1

About Anne‐Lise Børresen‐Dale

Anne‐Lise Børresen‐Dale is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (9 papers), Cancer Genomics and Diagnostics (6 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (527 citations), Oncology (446 citations) and Molecular Biology (822 citations). Anne‐Lise Børresen‐Dale has collaborated with scholars based in Norway, Sweden and France. Frequent co-authors include Thérese Sørlie, Per Eystein Lønning, Robert Tibshirani, Vessela N. Kristensen, Pei Wang, Anna Bergamaschi, Tina Hernandez‐Boussard, Jonathan R. Pollack, Young Ho Kim and Jörg Tost. Their work appears in journals such as Proceedings of the National Academy of Sciences, Bioinformatics and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact